Bulgaria's Donev Investments Holding increases stake in Sopharma

Donev Investment Holding bought 15,500 shares in Sopharma in deals priced at 3.14 levs ($1.88/1.61 euro) per share, the drug manufacturer said in a bourse filing.

The 15,500 shares are equal to 0.011% interest in Sopharma.

Donev Investment Holding is owned by Sopharma's CEO Ognyan Donev. In a separate statement on Wednesday, Sopharma said that Donev bought 15,428 shares in Sopharma through deals at a weighted average price of 3.13 levs also on September 21.

Indirectly, Ognyan Donev is the biggest shareholder in Sopharma, as he controls a 25.7% stake through Donev Investments Holding. Donev is also a major shareholder in Sopharma's second-biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.7% interest in Sopharma.

As at 12:45 CET on Wednesday, Sopharma shares traded at 3.14 levs on the Bulgarian Stock Exchange, unchanged from their previous closing price.

(1 euro = 1.95583 levs)